Wide Awake Local Anesthesia No Tourniquet (WALANT)

April 4, 2022 updated by: Rennes University Hospital
The main objective is to assess patient's satisfaction regarding pure local anaesthesia and without use of a tourniquet (WALANT Technique) for trigger finger release surgery.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

57

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Plérin, France, 22190
        • Centre Hospitalier Privé de Plérin
      • Rennes, France, 35033
        • CHU de Rennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with Isolated Trigger finger, diagnosis confirmed by sonography and indication of surgical release

Description

Inclusion Criteria:

  • Patients of age
  • Isolated Trigger finger, diagnosis confirmed by sonography and with indication of surgical release
  • Patients protected by health insurance
  • Patients who have received proper information on the current research proctol, and did not refuse to enter the study

Exclusion Criteria:

  • Hand vascular disorders ( History of finger replantation surgery, clinical signs of poor hand vascularization
  • Hypersensitivy to Xylocain or Adrenalin or one of it's components
  • Other surgical act planned to be performed during the same anaesthesia
  • Pregnant or Breastfeeding women
  • Patients of age and under the protection of a conservator, patients deprived of liberty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction
Time Frame: one day after surgery
Patient's agreement to use WALANT for possible surgeries to come and Patient's agreement to refer WALANT to his close relatives if they were to undergo surgery
one day after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2017

Primary Completion (Actual)

November 12, 2018

Study Completion (Actual)

November 12, 2018

Study Registration Dates

First Submitted

September 6, 2018

First Submitted That Met QC Criteria

September 6, 2018

First Posted (Actual)

September 10, 2018

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

April 4, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 35RC17-3065_WALANT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Finger Disorder

Clinical Trials on WALANT Technique

3
Subscribe